These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 28043788

  • 1. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
    Muñoz-Torrico M, Caminero Luna J, Migliori GB, D'Ambrosio L, Carrillo-Alduenda JL, Villareal-Velarde H, Torres-Cruz A, Flores-Ergara H, Martínez-Mendoza D, García-Sancho C, Centis R, Salazar-Lezama MÁ, Pérez-Padilla R.
    Rev Port Pneumol (2006); 2017; 23(1):27-30. PubMed ID: 28043788
    [Abstract] [Full Text] [Related]

  • 2. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [Abstract] [Full Text] [Related]

  • 3. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.
    Clin Infect Dis; 2008 Aug 15; 47(4):450-7. PubMed ID: 18616396
    [Abstract] [Full Text] [Related]

  • 4. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Reimann M, Schaub D, Kalsdorf B, Runge C, Carballo PS, Terhalle E, Salzer HJF, Lange C, Heyckendorf J.
    Int J Tuberc Lung Dis; 2019 Jan 01; 23(1):93-98. PubMed ID: 30674380
    [Abstract] [Full Text] [Related]

  • 5. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 6. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
    Pan Y, Yu Y, Yi Y, Dou X, Lu J, Zhou L.
    BMC Infect Dis; 2023 Mar 15; 23(1):162. PubMed ID: 36922787
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 8. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M, Caminero-Luna J, Migliori GB, D'Ambrosio L, Carrillo-Alduenda JL, Villareal-Velarde H, Torres-Cruz A, Flores-Vergara H, Martínez-Mendoza D, García-Sancho C, Centis R, Salazar-Lezama MÁ, Pérez-Padilla R.
    Arch Bronconeumol; 2017 May 15; 53(5):245-250. PubMed ID: 28089216
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, Jarlier V, Robert J.
    Int J Tuberc Lung Dis; 2018 Jan 01; 22(1):54-59. PubMed ID: 29297426
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, Zhang X, Xiong G, Chen J, Xu X, Li W, Li J.
    J Antimicrob Chemother; 2015 Feb 01; 70(2):456-62. PubMed ID: 25266071
    [Abstract] [Full Text] [Related]

  • 11. Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study.
    Gómez-Gómez A, Magaña-Aquino M, López-Meza S, Aranda-Álvarez M, Díaz-Ornelas DE, Hernández-Segura MG, Salazar-Lezama MÁ, Castellanos-Joya M, Noyola DE.
    Arch Med Res; 2015 Feb 01; 46(2):142-8. PubMed ID: 25704633
    [Abstract] [Full Text] [Related]

  • 12. Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C, German TBNET Group.
    Emerg Infect Dis; 2008 Nov 01; 14(11):1700-6. PubMed ID: 18976552
    [Abstract] [Full Text] [Related]

  • 13. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 01; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 14. Treatment responses in multidrug-resistant tuberculosis in Germany.
    Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C.
    Int J Tuberc Lung Dis; 2018 Apr 01; 22(4):399-406. PubMed ID: 29562987
    [Abstract] [Full Text] [Related]

  • 15. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018 Apr 01; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 16. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM.
    Acta Med Indones; 2018 Jan 01; 50(1):1-2. PubMed ID: 29686169
    [Abstract] [Full Text] [Related]

  • 17. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM, Sachdeva KS, Dewan PK, Rade K, Nair SA, Pant R, Khaparde SD.
    PLoS One; 2018 Jan 01; 13(4):e0193903. PubMed ID: 29641576
    [Abstract] [Full Text] [Related]

  • 18. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ, Kempker RR, Kipiani M, Tukvadze N, Howards PP, Narayan KM, Blumberg HM.
    PLoS One; 2014 Jan 01; 9(4):e94890. PubMed ID: 24736471
    [Abstract] [Full Text] [Related]

  • 19. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A, Parthasarathy G, Burma SP, Sugunan AP, Vijayachari P.
    Indian J Tuberc; 2015 Jan 01; 62(1):23-8. PubMed ID: 25857562
    [Abstract] [Full Text] [Related]

  • 20. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.
    Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E.
    Int J Tuberc Lung Dis; 2014 Sep 01; 18(9):1019-25. PubMed ID: 25189547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.